We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
West has been on a multi-year journey to evolve its manufacturing strategy based on customer needs. With an advanced global network of manufacturing sites, we work each day to improve our service to customers and help them to mitigate the risks of drug development and delivery.
Multiple sites of supply enable improved service levels and availability of surge capacity to support demand. Customer surge demand could come in the form of a recently approved drug launch, a new market for an existing drug, or an existing drug paired with a new product from West. Multiple West sites also enable customers to outsource more of their manufacturing processes to West. These processes could include pharmaceutical washing and steam sterilization allowing our customers to focus their expertise on the manufacturing of drug products.As an example, West’s state-of-the-art facility in Waterford, Ireland is the first West site in Europe to offer steam sterilization capability.
West is also working towards a global harmonization strategy for our pharmaceutical wash to our already harmonized steam sterilization processes. This enables a harmonized regulatory strategy around our ready-to-sterilize and ready-to-use components. West’s Kinston, NC facility will become the third global site to have steam sterilization capability in 2020. In addition to Kinston and Waterford currently offering Westar® Select RS components, successful harmonization will allow both sites to also offer Westar Select RU components, our next generation quality offering.
Our goal, through process harmonization and simplifying regulatory strategy, provides additional supply chain flexibility, capacity, and reliability across our global footprint. West can mitigate supply risks for our customers and improve our service to them at the same time. We can work by the side of our customers to ensure consistent, safe, and effective delivery of medicines to patients.
Westar® is a registered trademark of West Pharmaceutical Services, Inc., in the United States and other jurisdictions.
The AccelTRA<sup>®</sup> components program was developed to help generics manufacturers meet increasing quality standards, facilitate fast response to market variability and standardize around a next generation formulation for simplicity. Initially introduced with stopper configurations in 13mm and 20mm serum and lyo formats, the benefits under the program support the needs of the generics market to minimize the risk for quality by having an industry leading Extractables package, in addition to an optimized supply chain, ensuring 6-week lead times on commercial orders.
During the week of June 24 – 28, the West Ambassador Interns had the opportunity to mentor a group of high school seniors from the Downingtown S.T.E.M. Academy. The students were participating in a practicum at West as a requirement for graduation. During the week, each intern was assigned a S.T.E.M. student who shadowed the interns’ daily activities. We taught them about our respective departments and the responsibilities we have as part of the West team. The students also received lab tours and participated in a telepresence Lunch and Learn with the Scottsdale, Ariz., facility to learn more about West and its products.
<span>Before an injectable biologic can be formulated and manufactured, an extensive series of pre-formulation checks are necessary to ensure that developers avoid formulating an unstable, non-viable product¹. Developers must determine whether the injectable biologic will break down within the intended formulation or the manufacturing process. The drug must be thermally stable, possibly resistant to oxidation, tolerate variations in light, and other environmental stresses placed on it during manufacturing and packaging.</span>
West is thrilled to announce that Thaisa Silvestre, Director, Sales, Brazil, was recently named as 2019 HBA Rising Star.
<span>West is pleased to announce that it has joined the Pharmaceutical Supply Chain Initiative (PSCI). PSCI is a group of major pharmaceutical companies, all of which are West customers, that formed to “support pharmaceutical suppliers in efforts to operate in a manner consistent with industry expectations about ethics, labor, health and safety, environment and management systems.” PSCI members believe that through the application of principles for responsible supply chain management, better social, economic and environmental outcomes will result for all involved in the pharmaceutical supply chain. This includes improved conditions for workers, economic development and a cleaner environment for local communities.</span>
English
Chinese
